NCT01429181View on ClinicalTrials.gov

Efficacy & Safety Study of Nonracemic Methadone for the Relief of Chronic Peripheral Neuropathic Pain

PHASE2CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

September 30, 2014

Study Completion Date

December 31, 2014

Conditions
Diabetic Peripheral Neuropathic Pain
Interventions
DRUG

Non-racemic mixture of methadone HCl

Non-racemic mixture of methadone HCl capsules, 5 mg

All Listed Sponsors
lead

MetaPharm, Inc.

INDUSTRY

NCT01429181 - Efficacy & Safety Study of Nonracemic Methadone for the Relief of Chronic Peripheral Neuropathic Pain | Biotech Hunter | Biotech Hunter